Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myeloma

Annals of Hematology

Volumn 85, Issue 5, 2006, Pages 308-314

  Vela Ojeda, J ^a,b,f   Garcia Ruiz Esparza M A ^a   Reyes Maldonado, E ^b   Jimenez Zamudio L ^b   Garcia Latorre E ^b   Moreno Lafont, M ^b   Estrada Garcia I ^b   Mayani, H ^c   Montiel Cervantes, L ^a,b   Tripp Villanueva, F ^a   Ayala Sanchez M ^a   Garcia Leon L D ^a   Borbolla Escoboza, J R ^d,e  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL DE ONCOLOGÍA   (Mexico)

^d Hospital San Jose Tec de Monterrey   (Mexico)

^e SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^f Hospital Especialidades C M La Raza   (Mexico)

Author keywords

Dendritic cells; G CSF; Mobilization; Regulatory T cells

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; B LYMPHOCYTE; BLOOD SAMPLING; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG DOSE REGIMEN; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKAPHERESIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; MULTIPLE MYELOMA; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, DIFFERENTIATION; CELL FRACTIONATION; DENDRITIC CELLS; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LYMPHOCYTES; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 33646713892     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0090-8     Document Type: Article

References (34)

1. Bensinger WI, Weaver CH, Appelbaum FR (1995) Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655-1658
2. Bolwell B, Sobecks R, Pohlman B, Andresen S, Theil K, Serafino S, Rybicki L, Kalaycio M (2003) Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone. Bone Marrow Transplant 31:95-98
3. Chin-Yee I, Keeney M, Anderson L, Nayar R, Sutherland DR (1997) Current status of CD34+ cell analysis by flow cytometry. The ISHAGE Guidelines. Clin Immunol 17:21-29
4. Damiani D, Fanin R, Silvestri F (1997) Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood 90:36-42
5. Dhodapkar MV, Geller MD, Chang DH, Shimizu K, Fujii SI, Dhodapkar KM, Krasovsky J (2003) A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J Exp Med 197:1667-1676
6. Dreger P, Haferlach T, Eckstein V (1994) G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87:609-613
7. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330-336
8. Gasparetto C, Gasparetto M, Morse M, Rooney B, Vredenburgh JJ, Long GD, Rizzieri DA, Loftis J, Chao NJ, Smith C (2002) Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-ligand and G-CSF or GM-CSF. Cytokine 18:8-19
9. Gavin MA (2002) Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat Immunol 3:33-41
10. Lanza F, Healy J, Sutherland DR (2001) Structural and functional features of the CD34 antigen: An update. J Biol Regul Homeost Agents 15:1-13
11. Levings MK, Sangregorio R, Galbiati F, Squadrone S, De Waal Malefyt R, Roncarolo MG (2001) IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166:5530-5539
12. Liso A, Stockerl-Goldstein K, Aufferman-Gretziner S, Benike C, Reichardt V, Van Beckhoven A, Rajapaksa R, Engelman E, Blume K, Levy R (2000) Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 6:621-627
13. Lonial S, Hicks M, Rosenthal H, Langston A, Redei I, Torre C, Duenzl M, Feinstein B, Cherry J, Waller E (2004) A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Biol Blood Marrow Transplant 10:848-857
14. McHugh RS (2002) CD4+CD25+ immunoregulatory T cells: Gene expression analysis reveals a functional role of the glucocorticoid-induced TNF receptor. Immunity 16:311-323
15. Miller JS, Prosper F, McCullar V (1997) Natural killer (NK) cells are functionally abnormal and NK cells progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 90:3098-3105
16. Morse M, Zhou L, Tedder T, Lyerly H, Smith C (1997) Generation of dendritic cells in vitro from peripheral blood mononuclear cells with GM-CSF, IL-4 and TNF-α. Ann Surg 226:6-16
17. Morse MA, Nair S, Fernandez-Casal M, Deng Y, St Peter M, Williams R, Hobeika A, Mosca P, Clay T, Ian Cumming R, Fisher E, Clavien P, Proia AD, Niedzwiecki D, Caron D, Lyerly H (2000) Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer. J Clin Oncol 18(23):3883-3893
18. Peron JM, Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR (1998) Flt3-ligand administration inhibits liver metastases: Role of NK cells. J Immunol 161:6164-6170
19. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, Mariotti A, Scambia G, d'Onofrio G, Leone G (2002) Role for granulocyte colony-stimulating factor in the generation of human T regulatory type I cells. Blood 100(7):2562-2571
20. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3):1151-1164
21. Sheridan WP, Begley CG, Juttner CA (1992) Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640-644
22. Shier LR, Schultz KR, Imren S, Regan J, Issekutz A, Sadek I, Gilman A, Luo Z, Panzarella T, Eaves CJ, Couban S (2004) Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors. Biol Blood Marrow Transplant 10:624-634
23. Shimizu J, Yamazaki S, Sakaguchi S (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity. J Immunol 162:5211-5218
24. Shpall EJ, Wheeler CA, Turner SA (1999) A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients. Blood 93:2491-2501
25. Siena S, Bregni M, Brando B, Ravagnani F, Bonadona G, Gianni AM (1989) Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74:1905-1914
26. Simmet SJ, Stewart LA, Sweetenham J, Morgan G, Johnson PWM (2000) Autologous stem cell transplantation for malignancy: A systematic review of the literature. Clin Lab Haematol 22(2):61-72
27. Sosman JA, Stiff P, Moss SM, Sorokin P, Martone B, Bayer R, Van Besien K, Devine S, Stock W, Peace D, Chen Y, Long C, Gustin D, Viana M, Hoffman R (2001) Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion. J Clin Oncol 19:634-644
28. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-yee I (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 5:213-226
29. Theilgaard-Mönch K, Raaschou-Jensen K, Palm H, Schjodt K, Heilmann C, Vindelov L, Jaconsen N, Dickmeiss E (2001) Flow cytometry assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant 28:1073-1082
30. Timmerman JM, Levy R (1999) Dendritic cell vaccination for cancer immunotherapy. Annu Rev Med 50:507-529
31. To LB, Shepperd KM, Haylock DN (1990) Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18:442-449
32. Van Maurik A, Herber M, Wood KJ, Jones ND (2002) Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: Implications for anti-CD154 immunotherapy. J Immunol 169(10):5401-5404
33. Weaver CH, Birch R, Greco FA (1998) Mobilisation and harvesting of peripheral blood stem cells: Randomized evaluations of different doses of filgrastim. Br J Haematol 100:338-347
34. Woo EY, Chi CS, Goletz TJ, Schlienger K, Yeh H, Coukos G (2001) Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small lung cancer and late stage ovarian cancer. Cancer Res 61:4766-4772